Troponin and CKMB (creatine kinase MB) are two important cardiac markers used to diagnose myocardial infarction and other cardiovascular conditions.

Troponin is a protein found in the myocardium (cardiomyocytes) and has an important role in the contraction of the heart. There are three types of troponin: T, I and C. T and I troponins are released into the blood when there is damage to the cardiomyocyte tissue, as in the case of myocardial infarction. Measuring troponin levels in the blood is critical for the diagnosis of infarction, since levels rise rapidly after myocardial damage and remain elevated for several days. Troponin is highly reliable and is widely used as a marker to confirm cardiovascular events.

CKMB is an enzyme that is released into the blood when cardiomyocyte tissue is damaged. Although it is also used to detect infarction, CKMB levels rise faster than troponin and return to normal more quickly, making it less sensitive for diagnosing chronic cardiovascular damage.

Cholesterol, atherosclerotic markers and cardiac markers such as troponin and CKMB are critical tools for cardiovascular risk assessment and early diagnosis of cardiac conditions. Good management of cholesterol levels and monitoring of cardiological markers can help prevent and early diagnosis of serious cardiovascular events, providing physicians with the necessary data for appropriate treatment and monitoring of heart health.